Mckesson Stock Today

MCK Stock  USD 595.69  4.06  0.68%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Very Low

 
High
 
Low
McKesson is selling for 595.69 as of the 8th of February 2025. This is a 0.68% down since the beginning of the trading day. The stock's last reported lowest price was 591.13. McKesson has under 5 % chance of experiencing financial distress over the next 2 years, but has generated negative returns over the last 90 days. Note, on November 8, 2024, Representative Byron Donalds of US Congress acquired under $15k worth of McKesson's common stock.
Business Domain
Health Care Equipment & Services
IPO Date
15th of November 1994
Category
Healthcare
Classification
Health Care
McKesson Corporation provides healthcare services in the United States and internationally. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas. Mckesson Corp operates under Medical Distribution classification in the United States and is traded on New York Stock Exchange. The company has 125.33 M outstanding shares of which 1.6 M shares are now shorted by investors with about 2.17 days to cover. More on McKesson

Moving together with McKesson Stock

  0.64LH Laboratory Earnings Call This WeekPairCorr

Moving against McKesson Stock

  0.44VERO Venus ConceptPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

McKesson Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CEOBrian Tyler
Thematic Ideas
(View all Themes)
Old Names[Jade Leader Corp, McKesson Corporation]
Business ConcentrationHealth Care Providers & Services, Health Care Equipment & Services, Health Care, NYSE Composite, SP 500 Index, Nasdaq Benchmark Consumer, Wholesale, Macroaxis Picks, Obamacare Repeal, Health Care, Health Care Providers & Services, Medical Distribution, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover2.994.12
Way Down
Slightly volatile
Gross Profit Margin0.06440.0468
Significantly Up
Slightly volatile
Net Debt2.2 B3.2 B
Way Down
Very volatile
Total Current Liabilities63.2 B60.2 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total20.1 B19.2 B
Sufficiently Up
Slightly volatile
Total Assets81.4 B77.6 B
Sufficiently Up
Slightly volatile
Total Current Assets57.9 B55.2 B
Sufficiently Up
Slightly volatile
Total Cash From Operating Activities5.2 BB
Sufficiently Up
Slightly volatile
Debt Levels
McKesson can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand McKesson's financial leverage. It provides some insight into what part of McKesson's total assets is financed by creditors.
Liquidity
McKesson has 7.39 B in debt with debt to equity (D/E) ratio of 6.61, demonstrating that the company may be unable to create cash to meet all of its financial commitments. McKesson has a current ratio of 0.94, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for McKesson to invest in growth at high rates of return.

Change In Working Capital

(69.92 Million)
McKesson (MCK) is traded on New York Stock Exchange in USA. It is located in 6555 State Highway 161, Irving, TX, United States, 75039 and employs 45,000 people. McKesson is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 75.16 B. McKesson runs under Health Care Providers & Services sector within Health Care industry. The entity has 125.33 M outstanding shares of which 1.6 M shares are now shorted by investors with about 2.17 days to cover. McKesson has about 4.68 B in cash with 4.31 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 20.57.
Check McKesson Probability Of Bankruptcy
Ownership Allocation
McKesson maintains a total of 125.33 Million outstanding shares. The majority of McKesson outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in McKesson to benefit from reduced commissions. Accordingly, institutional holders are subject to a different set of regulations than regular investors in McKesson. Please pay attention to any change in the institutional holdings of McKesson as this could imply that something significant has changed or is about to change at the company. Please note that on November 8, 2024, Representative Byron Donalds of US Congress acquired under $15k worth of McKesson's common stock.
Check McKesson Ownership Details

McKesson Stock Institutional Holders

InstituionRecorded OnShares
Royal Bank Of Canada2024-09-30
1.7 M
Northern Trust Corp2024-09-30
1.4 M
T. Rowe Price Associates, Inc.2024-09-30
1.3 M
Legal & General Group Plc2024-09-30
1.2 M
Manufacturers Life Insurance Co2024-09-30
1.2 M
Arrowstreet Capital Limited Partnership2024-09-30
1.1 M
Wcm Investment Management2024-12-31
1.1 M
Amvescap Plc.2024-09-30
1.1 M
Goldman Sachs Group Inc2024-09-30
M
Vanguard Group Inc2024-09-30
12 M
Blackrock Inc2024-09-30
11.1 M
View McKesson Diagnostics

McKesson Historical Income Statement

At this time, McKesson's EBITDA is quite stable compared to the past year. Cost Of Revenue is expected to rise to about 357.9 B this year, although the value of Selling General Administrative will most likely fall to about 6.1 B. View More Fundamentals

McKesson Stock Against Markets

McKesson Corporate Directors

Bradley LermanIndependent DirectorProfile
Kenneth WashingtonIndependent DirectorProfile
M JacobsIndependent DirectorProfile
Marie KnowlesIndependent DirectorProfile
When determining whether McKesson is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if McKesson Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Mckesson Stock. Highlighted below are key reports to facilitate an investment decision about Mckesson Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in McKesson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy McKesson Stock please use our How to buy in McKesson Stock guide.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of McKesson. If investors know McKesson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about McKesson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.62)
Earnings Share
21.62
Revenue Per Share
2.5 K
Quarterly Revenue Growth
0.213
Return On Assets
0.0392
The market value of McKesson is measured differently than its book value, which is the value of McKesson that is recorded on the company's balance sheet. Investors also form their own opinion of McKesson's value that differs from its market value or its book value, called intrinsic value, which is McKesson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because McKesson's market value can be influenced by many factors that don't directly affect McKesson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between McKesson's value and its price as these two are different measures arrived at by different means. Investors typically determine if McKesson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, McKesson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.